While the UK is performing well in its vaccine rollout, there are thoughts things could move even quicker. With vials known to contain extra doses in case of spillage, and also the inevitable scenario of some patients missing their appointments, should vaccination centres offer waiting lists for others to receive the dose at the end of a day to prevent wastage and speed up the process?
The priority groups are not the only source of contention when it comes to the vaccine.
Trials for the AstraZeneca and Pfizer vaccines produced differing results, with efficacy against symptomatic infections at 70.4 percent for AstraZeneca, compared with the 95 percent efficacy from Pfizer/BioNTech.
It has led to some wanting to choose between which vaccine they receive.
Confusion over the AstraZeneca vaccine’s efficacy emerged after interim late-stage trial results announced in late November acknowledged that people in its clinical trial accidentally got different doses.
But recent findings from Oxford and AstraZeneca appear to show that the vaccine’s efficacy actually increases when the second dose is delivered more than 12 weeks after the first.
This has been a major boost to the UK government’s vaccine rollout, which decided to delay the second shots to maximise the amount of people vaccinated…